ARCHIVES

New benchmark for CCSG award funding will be lowered from 20 percent of NCI research base to 15 percent, the program’s “reality ratio,” Karen Antman tells NCAB.

This article is from The Cancer Letter archive.

Vol. 30 No. 38 | October 8, 2004

Download PDF Visit The Full Archive

Related Articles

New Jersey Center Takes Slice of DOE Budget for Cancer

January 8, 1988

In Brief: Upton Okays Laetrile Clinical Trials, To Seek Protocols From Clinicians For IND Request

October 6, 1978

Also in this 8-page issue: John Montgomery, a founder of BioCryst Pharmaceuticals and a former member of the President’s Cancer Panel, dead.

July 2, 2004

NIH Plans Conference On DCIS Diagnosis, Management

July 17, 2009

NTP Board Okays Three Cooperative Agreement Concepts, Including Corn Oil Carcinogens is Test

October 7, 1983

DCT Board Committee Recommends Limited Start On In Vitro Screening Program

January 18, 1985